Wird geladen...
SPRED1 deletion confers resistance to MAPK inhibition in melanoma
Functional evaluation of genetic lesions can discover a role in cancer initiation and progression and help develop novel therapeutic strategies. We previously identified the negative MAPK regulator SPRED1 as a novel tumor suppressor in KIT-driven melanoma. Here, we show that SPRED1 is also frequentl...
Gespeichert in:
| Veröffentlicht in: | J Exp Med |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Rockefeller University Press
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7927430/ https://ncbi.nlm.nih.gov/pubmed/33306107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20201097 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|